Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Impact
Culture
Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Global Shifts
Empowered consumers
Healthier humans
Future organisations
Business for better
Safer societies
Sustainable world
Industries
Consumer and manufacturing
Defence and security
Energy and utilities
Financial services
Government and public sector
Health
Life sciences
Transport
Services
Set growth strategy
Build brands, products, and services
Reimagine AI, digital, and data
Improve organisational performance
Deliver complex programmes
Empower your people
Impact
Culture

Health

Showing 21-30 of 299 results
Sort by:
Insight

Brexit: the eye of the storm

The UK life sciences sector will undoubtedly be affected by the Brexit after the decision that Article 50 will be triggered by the end of March 2017; and it needs to start preparing now for the uncertainties ahead.
Insight

Place-based commissioning - Radical thinking required

Insight

Is your GPO contract expiring? Now’s the time to rethink your healthcare supply chain strategy

Forces impacting the healthcare landscape, such as hospital consolidation and incentive alignment, combined with an expiring contract, provide an opportunity for procurement leaders to address their supply chains by determining the future role of the group purchasing organization (GPO).
Insight

Reinventing medical societies: managing costs and delivering revenue in order to drive relevance and sustainability

With the healthcare industry undergoing significant transformation driven by market consolidation, technology, new care models and regulations, medical societies need to reinvent their business models to remain relevant and sustainable.
Insight

Mobile health: policy and regulation for intelligent healthcare

Insight

Pharma and big data – the commercial opportunity

Big data can unlock the potential of existing medicines. By analysing data about their existing treatments, pharma companies have a real opportunity to prevent health problems that may be associated with the drugs.
Insight

Securing transformational change in the NHS

If the NHS is to survive in a post-austerity era, transformational change is essential. Without it, the NHS will be unable to meet the needs of an ageing population or afford the rising cost of treatment, and ultimately faces oblivion. However, achieving transformational change is easier said than done.
Insight

Journey to profitability and compliance by establishing successful outsourcing relationships in China

Insight

10 simple rules for creating an effective portfolio of regulated documents

Insight

How can healthcare associations redesign their operating models to achieve non-dues revenue growth?

We dive deeper into operating model considerations for healthcare societies and associations looking to achieve non-dues revenue growth.